AS
Aspen Aerogels, Inc.
ASPN · NYSE
$5.23 -1.42% (-$0.08)
1M +5.88%
Market Cap $431.4M
P/E Ratio -
Div. Yield -
ROE 53.29%
Bulios Fair Price
$6.94
32.8% upside
Current Price
$5.23
Undervalued Fair Value Overvalued
According to Bulios Fair Price, ASPN is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
3/9Valuation
76 /100
Cheap P/B 2.24x
P/FCF 11.49x
P/S 2.13x
Growth
76 /100
Growing Book val. growth 19.26%
Rev. growth 14.55%
FCF growth N/A
Profitability
60 /100
Moderate FCF margin 18.58%
Op. margin 100.90%
Gross margin 2.68%
Quality
48 /100
Average Asset turnover 0.51x
ROA 32.12%
ROIC 60.71%
Debt
62 /100
Moderate Current ratio 2.52x
Int. coverage -22.65x
Debt/Equity 0.65x
Stability
5 /100
Unstable Profitable years 0
EPS volatility 1,724.22%
Beta 2.97x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ASPN
Online
Sector
Basic Materials
Industry
Chemicals - Specialty
CEO
Donald R. Young
Employees
854
Headquarters
Northborough
Upcoming events
05 NOV
Earnings
Upcoming earnings report